We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection

By LabMedica International staff writers
Posted on 18 Apr 2024

Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. More...

Now, a unique hand-warming technology has been specifically designed to enhance the collection of high-quality blood samples from the fingertip.

The hand warmer designed to improve the collection of high-quality capillary blood samples has been developed by Babson Diagnostics (Austin, TX, USA) in collaboration with experts in biomedical engineering who study the impact of heat on the human body in the design of therapeutic devices. The Babson Hand Warmer is part of its BetterWay blood testing ecosystem, which combines Babson’s proprietary sample preparation and laboratory technologies with the BD MiniDraw Capillary Collection System. This system is the result of a strategic partnership between Babson and BD (Becton, Dickinson and Company, Franklin Lakes, NJ, USA). Slated for commercial release this year, BetterWay revolutionizes blood testing by requiring just a small amount of blood from a finger prick, while still delivering results that clinicians and patients can rely on. The system is designed so that any trained healthcare worker can collect samples effectively, enabling blood testing services at convenient locations like retail pharmacies.

For developing the hand warmer, Babson collaborated with the University of Texas at Austin (Austin, TX, USA) to create designs that are ergonomic and easy to use in retail settings. The device was designed to provide simultaneous warming of the hand with collection without impeding access to fingers. A team of UT students produced an initial prototype, which was then refined by a professional engineering team into a production-ready model. Babson conducted a validation study with staff at pharmacy partners to meet U.S. Food and Drug Administration regulatory standards. The feedback from pharmacy staff trained as collection technicians and from customers who used the BetterWay blood test was exceptionally positive. The Babson Hand Warmer is now listed as a Class II medical device by the FDA.

“The Babson Hand Warmer supports blood collection from the finger, providing simultaneous warming of the hand with collection to create a repeatable and more pleasant blood testing experience for the customer,” said Roy Barr, Babson’s vice president of research and development. “The device is another example of how BetterWay is putting the needs of the customer first.”

Related Links:
Babson Diagnostics
University of Texas at Austin
BD


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Immunology

view channel
Image: The simple blood marker can predict which lymphoma patients will benefit most from CAR T-cell therapy (Photo courtesy of Shutterstock)

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.